Haemonetics (HAE)’s Insider Dan Goldstein Sells 518 Shares of the Company; Last Week Kraton (KRA) Analysts

April 11, 2018 - By Annabelle Johnson

Haemonetics Corporation (NYSE:HAE) Logo

Kraton Corporation (NYSE:KRA) Ratings Coverage

Among 5 analysts covering Kraton Performance Polymers (NYSE:KRA), 3 have Buy rating, 1 Sell and 1 Hold. Therefore 60% are positive. Kraton Performance Polymers had 8 analyst reports since October 27, 2015 according to SRatingsIntel. The rating was maintained by UBS with “Sell” on Wednesday, February 21. The stock of Kraton Corporation (NYSE:KRA) has “Sell” rating given on Wednesday, October 25 by UBS. The stock of Kraton Corporation (NYSE:KRA) has “Buy” rating given on Thursday, October 26 by SunTrust. The firm has “Sell” rating by UBS given on Tuesday, October 27. SunTrust maintained the shares of KRA in report on Wednesday, October 11 with “Buy” rating. KeyBanc Capital Markets maintained Kraton Corporation (NYSE:KRA) on Friday, September 1 with “Hold” rating. See Kraton Corporation (NYSE:KRA) latest ratings:

20/03/2018 Broker: Loop Capital Markets Rating: Buy New Target: $76.0
21/02/2018 Broker: UBS Old Rating: Sell New Rating: Sell Old Target: $30 New Target: $33 Maintain
26/10/2017 Broker: SunTrust Rating: Buy New Target: $60.0 Maintain
25/10/2017 Broker: UBS Rating: Sell Old Target: $28 New Target: $30 Maintain

The stock increased 1.78% or $1.28 during the last trading session, reaching $73.21. About 332,049 shares traded. Haemonetics Corporation (NYSE:HAE) has risen 82.56% since April 11, 2017 and is uptrending. It has outperformed by 71.01% the S&P500.

Analysts await Haemonetics Corporation (NYSE:HAE) to report earnings on May, 14. They expect $0.43 earnings per share, up 10.26% or $0.04 from last year’s $0.39 per share. HAE’s profit will be $22.98M for 42.56 P/E if the $0.43 EPS becomes a reality. After $0.62 actual earnings per share reported by Haemonetics Corporation for the previous quarter, Wall Street now forecasts -30.65% negative EPS growth.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company has market cap of $3.91 billion. The firm operates through five divisions: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It currently has negative earnings. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma clients to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection and processing products.

Dan Goldstein, an insider and also VP – Corporate Controller of the exchange-traded company Haemonetics Corp made sell. He sold 518 shares of the corporation with the insider trading deal valued at $28,307 US Dollars – which is based on a market stock price of $54.6 per share. The regulatory filing shows that Dan Goldstein now has in hand exactly 0.01% of the Massachusetts-based company’s market capitalization

Investors sentiment decreased to 1.11 in Q4 2017. Its down 0.17, from 1.28 in 2017Q3. It worsened, as 20 investors sold Haemonetics Corporation shares while 77 reduced holdings. 48 funds opened positions while 60 raised stakes. 50.89 million shares or 3.15% less from 52.55 million shares in 2017Q3 were reported. Hillsdale Management Inc holds 23,000 shares. State Teachers Retirement Sys accumulated 108,526 shares or 0.01% of the stock. Healthcor Mgmt L P accumulated 1.45M shares. Strs Ohio invested 0.01% in Haemonetics Corporation (NYSE:HAE). Moreover, Voya Invest Mgmt Ltd Liability Corporation has 0% invested in Haemonetics Corporation (NYSE:HAE) for 33,273 shares. Tci Wealth Advsrs invested 0% in Haemonetics Corporation (NYSE:HAE). Fny Managed Accounts Ltd holds 0% of its portfolio in Haemonetics Corporation (NYSE:HAE) for 58 shares. Bogle Mngmt Lp De invested in 215,757 shares or 0.92% of the stock. Tiaa Cref Investment Lc holds 0.01% or 270,197 shares in its portfolio. American Intl Gp Inc Inc holds 0.01% or 42,271 shares in its portfolio. Wellington Mngmt Gru Llp holds 3.79 million shares. Reilly Fin Llc has 170 shares for 0% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) reported 12,132 shares stake. Picton Mahoney Asset owns 32,800 shares. Texas Permanent School Fund owns 35,703 shares.

Among 10 analysts covering Haemonetics Corporation (NYSE:HAE), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Haemonetics Corporation has $80.0 highest and $28 lowest target. $51.83’s average target is -29.20% below currents $73.21 stock price. Haemonetics Corporation had 28 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Tuesday, August 2 with “Buy”. The rating was upgraded by Barrington Research on Tuesday, November 8 to “Outperform”. CJS Securities downgraded Haemonetics Corporation (NYSE:HAE) on Tuesday, September 20 to “Market Perform” rating. The firm has “Hold” rating by Craig Hallum given on Wednesday, November 8. Goldman Sachs upgraded the shares of HAE in report on Monday, May 16 to “Neutral” rating. Jefferies maintained the shares of HAE in report on Thursday, August 31 with “Buy” rating. Benchmark maintained Haemonetics Corporation (NYSE:HAE) rating on Monday, November 7. Benchmark has “Hold” rating and $34 target. The company was upgraded on Tuesday, July 28 by Barrington Research. Morgan Stanley maintained Haemonetics Corporation (NYSE:HAE) on Friday, October 6 with “Equal-Weight” rating. The firm has “Buy” rating by Jefferies given on Tuesday, June 20.

Since January 2, 2018, it had 0 insider purchases, and 3 selling transactions for $484,765 activity. Shares for $28,097 were sold by Basil Michelle L on Tuesday, March 6. 114 shares were sold by Scanlan Jacqueline, worth $8,234 on Tuesday, March 6. Shares for $448,434 were sold by KROLL MARK W.

Investors sentiment increased to 1.27 in 2017 Q4. Its up 0.02, from 1.25 in 2017Q3. It increased, as 10 investors sold Kraton Corporation shares while 69 reduced holdings. 54 funds opened positions while 46 raised stakes. 28.49 million shares or 1.40% less from 28.89 million shares in 2017Q3 were reported. Delta Cap Mgmt Limited Liability Corp invested in 4,485 shares. Meridian Investment Counsel holds 5,000 shares. Teachers Retirement Of The State Of Kentucky holds 0.01% of its portfolio in Kraton Corporation (NYSE:KRA) for 9,100 shares. Macquarie Grp Ltd holds 11,300 shares. D E Shaw Inc reported 53,038 shares stake. California Public Employees Retirement holds 0.01% or 78,863 shares. Comml Bank Of America De reported 0% of its portfolio in Kraton Corporation (NYSE:KRA). Northern Tru Corporation accumulated 642,134 shares. Aperio Gp Incorporated Ltd Liability Com owns 6,690 shares. 142,700 are held by Skylands Capital Limited Liability Co. Acadian Asset Mgmt Limited Co owns 46,293 shares or 0.01% of their US portfolio. Arrowstreet Cap L P invested in 0.02% or 171,823 shares. Silver Capital Mngmt Lc reported 2.22% in Kraton Corporation (NYSE:KRA). California State Teachers Retirement Systems stated it has 0% in Kraton Corporation (NYSE:KRA). Teacher Retirement Of Texas holds 0% or 10,853 shares in its portfolio.

Kraton Corporation produces and sells styrenic block copolymers and other engineered polymers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $1.59 billion. The firm offers performance products comprising unhydrogenated SBCs, which are primarily used in paving, roofing, adhesives, sealants, coatings, and footwear applications; and specialty polymers consisting of hydrogenated SBCs that are used in polymer modification, lubricant additives, personal care, adhesives and coatings, and cable gels, as well as in medical, industrial, consumer, and other applications. It has a 16.29 P/E ratio. It also provides isoprene rubber products that have applications in medical products, paints, coatings, and specialized footwear; and isoprene rubber latex products primarily for use in medical, healthcare, and personal care products, such as synthetic surgical gloves and condoms, as well as in food contact operations.

The stock increased 3.17% or $1.54 during the last trading session, reaching $50.09. About 197,165 shares traded. Kraton Corporation (NYSE:KRA) has risen 66.15% since April 11, 2017 and is uptrending. It has outperformed by 54.60% the S&P500.

Since October 27, 2017, it had 0 insider purchases, and 2 sales for $381,460 activity. Another trade for 1,042 shares valued at $52,100 was sold by Fogarty Kevin Michael. 6,950 shares were sold by Simmons James Leo, worth $329,360 on Friday, October 27.

Kraton Corporation (NYSE:KRA) Institutional Positions Chart